Literature DB >> 26834947

Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer.

Jacobus Fa Jansen1, Yonggang Lu1, Gaorav Gupta1, Nancy Y Lee1, Hilda E Stambuk1, Yousef Mazaheri1, Joseph O Deasy1, Amita Shukla-Dave1.   

Abstract

AIM: To investigate the merits of texture analysis on parametric maps derived from pharmacokinetic modeling with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as imaging biomarkers for the prediction of treatment response in patients with head and neck squamous cell carcinoma (HNSCC).
METHODS: In this retrospective study, 19 HNSCC patients underwent pre- and intra-treatment DCE-MRI scans at a 1.5T MRI scanner. All patients had chemo-radiation treatment. Pharmacokinetic modeling was performed on the acquired DCE-MRI images, generating maps of volume transfer rate (K(trans)) and volume fraction of the extravascular extracellular space (ve). Image texture analysis was then employed on maps of K(trans) and ve, generating two texture measures: Energy (E) and homogeneity.
RESULTS: No significant changes were found for the mean and standard deviation for K(trans) and ve between pre- and intra-treatment (P > 0.09). Texture analysis revealed that the imaging biomarker E of ve was significantly higher in intra-treatment scans, relative to pretreatment scans (P < 0.04).
CONCLUSION: Chemo-radiation treatment in HNSCC significantly reduces the heterogeneity of tumors.

Entities:  

Keywords:  Dynamic contrast-enhanced magnetic resonance imaging; Head and neck squamous cell carcinomas; Image texture analysis; Tumor heterogeneity

Year:  2016        PMID: 26834947      PMCID: PMC4731352          DOI: 10.4329/wjr.v8.i1.90

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  28 in total

1.  Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis.

Authors:  A Karahaliou; K Vassiou; N S Arikidis; S Skiadopoulos; T Kanavou; L Costaridou
Journal:  Br J Radiol       Date:  2010-04       Impact factor: 3.039

2.  Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.

Authors:  Anuj Goenka; Luc G T Morris; Shyam S Rao; Suzanne L Wolden; Richard J Wong; Dennis H Kraus; Nisha Ohri; Jeremy Setton; Benjamin H Lok; Nadeem Riaz; Borys R Mychalczak; Heiko Schoder; Ian Ganly; Jatin P Shah; David G Pfister; Michael J Zelefsky; Nancy Y Lee
Journal:  Int J Cancer       Date:  2013-03-29       Impact factor: 7.396

Review 3.  Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma.

Authors:  Jacobus F A Jansen; Jason A Koutcher; Amita Shukla-Dave
Journal:  Angiogenesis       Date:  2010-04-11       Impact factor: 9.596

Review 4.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

Authors:  Nola Hylton
Journal:  J Clin Oncol       Date:  2006-07-10       Impact factor: 44.544

5.  Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.

Authors:  Jeremy Setton; Nicola Caria; Jonathan Romanyshyn; Lawrence Koutcher; Suzanne L Wolden; Michael J Zelefsky; Nicholas Rowan; Eric J Sherman; Matthew G Fury; David G Pfister; Richard J Wong; Jatin P Shah; Dennis H Kraus; Weiji Shi; Zhigang Zhang; Karen D Schupak; Daphna Y Gelblum; Shyam D Rao; Nancy Y Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-16       Impact factor: 7.038

6.  Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?

Authors:  L Alic; M van Vliet; C F van Dijke; A M M Eggermont; J F Veenland; W J Niessen
Journal:  Phys Med Biol       Date:  2011-02-18       Impact factor: 3.609

7.  Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck.

Authors:  Jun-Ichi Asaumi; Yoshinobu Yanagi; Hironobu Konouchi; Miki Hisatomi; Hidenobu Matsuzaki; Kanji Kishi
Journal:  Oral Oncol       Date:  2004-07       Impact factor: 5.337

Review 8.  Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Alan Jackson; James P B O'Connor; Geoff J M Parker; Gordon C Jayson
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

Review 9.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

Review 10.  Improving tumour heterogeneity MRI assessment with histograms.

Authors:  N Just
Journal:  Br J Cancer       Date:  2014-09-30       Impact factor: 7.640

View more
  17 in total

Review 1.  "Radio-oncomics" : The potential of radiomics in radiation oncology.

Authors:  Jan Caspar Peeken; Fridtjof Nüsslin; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-07-07       Impact factor: 3.621

Review 2.  Texture analysis of medical images for radiotherapy applications.

Authors:  Elisa Scalco; Giovanna Rizzo
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

Review 3.  Uterine myxoid leiomyosarcoma - a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation.

Authors:  Anca Maria Istrate-Ofiţeru; George Lucian Zorilă; Dan Ruican; Ana Maria Petrescu; Elena Iuliana Anamaria Berbecaru; Gabriela Camelia Roşu; Răzvan Grigoraş Căpitănescu; Rodica Daniela Nagy; Liliana Cercelaru; Antonie Edu; Dominic Gabriel Iliescu; Roxana Cristina Drăguşin
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

4.  CT Texture Analysis Potentially Predicts Local Failure in Head and Neck Squamous Cell Carcinoma Treated with Chemoradiotherapy.

Authors:  H Kuno; M M Qureshi; M N Chapman; B Li; V C Andreu-Arasa; K Onoue; M T Truong; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-12       Impact factor: 3.825

5.  Radiomic analysis for response assessment in advanced head and neck cancers, a distant dream or an inevitable reality? A systematic review of the current level of evidence.

Authors:  Amrita Guha; Steve Connor; Mustafa Anjari; Harish Naik; Musib Siddiqui; Gary Cook; Vicky Goh
Journal:  Br J Radiol       Date:  2019-11-06       Impact factor: 3.039

Review 6.  Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers.

Authors:  Maryam Gul; Kimberley-Jane C Bonjoc; David Gorlin; Chi Wah Wong; Amirah Salem; Vincent La; Aleksandr Filippov; Abbas Chaudhry; Muhammad H Imam; Ammar A Chaudhry
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

7.  Biomarkers from in vivo molecular imaging of breast cancer: pretreatment 18F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy.

Authors:  Francesca Gallivanone; Marta Maria Panzeri; Carla Canevari; Claudio Losio; Luigi Gianolli; Francesco De Cobelli; Isabella Castiglioni
Journal:  MAGMA       Date:  2017-02-28       Impact factor: 2.310

8.  A radiomic nomogram based on an apparent diffusion coefficient map for differential diagnosis of suspicious breast findings.

Authors:  Bin Hu; Ke Xu; Zheng Zhang; Ruimei Chai; Shu Li; Lina Zhang
Journal:  Chin J Cancer Res       Date:  2018-08       Impact factor: 5.087

9.  Exploring Applications of Radiomics in Magnetic Resonance Imaging of Head and Neck Cancer: A Systematic Review.

Authors:  Amit Jethanandani; Timothy A Lin; Stefania Volpe; Hesham Elhalawani; Abdallah S R Mohamed; Pei Yang; Clifton D Fuller
Journal:  Front Oncol       Date:  2018-05-14       Impact factor: 6.244

10.  Predicting chemoradiotherapy response of nasopharyngeal carcinoma using texture features based on intravoxel incoherent motion diffusion-weighted imaging.

Authors:  Yuhui Qin; Xiaoping Yu; Jing Hou; Ying Hu; Feiping Li; Lu Wen; Qiang Lu; Yi Fu; Siye Liu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.